Nacl + Glucose Viaflo Baxter (Sodium Chloride, Glucose Monohydrate)

Sodium chloride, the active ingredient in Nacl + Glucose Viaflo Baxter, is a IV electrolyte solution presented as an injectable solution for intravenous use. It helps restore fluid volume and electrolyte balance in patients requiring rapid rehydration or glucose supplementation. GNH USA supplies Nacl + Glucose Viaflo Baxter as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Nacl + Glucose Viaflo Baxter is used in clinical situations that require rapid fluid and electrolyte restoration. - Fluid replacement: Restores intravascular volume in dehydration, blood loss, or peri‑operative settings. - Electrolyte replenishment: Provides sodium and chloride to correct electrolyte deficits. - Hypoglycemia: Supplies glucose to raise blood sugar in acute low‑glucose episodes.

Adverse reactions may occur with any intravenous solution.

Common Side Effects: - Phlebitis or infusion site pain: irritation of the vein during administration. - Mild hypernatremia: transient rise in serum sodium. - Transient hyperglycemia: temporary increase in blood glucose levels. - Fluid overload: signs of edema or pulmonary congestion in susceptible patients. - Electrolyte imbalance: minor shifts in potassium or chloride.

Serious or Rare Side Effects: - Severe hypernatremia: neurological symptoms such as confusion or seizures. - Anaphylactic reaction: rare but possible hypersensitivity to formulation components. - Cardiac arrhythmia: precipitated by rapid electrolyte changes. - Infection at infusion site: bacterial contamination leading to local or systemic infection. - Metabolic acidosis: unlikely but reported with large volumes.

Careful assessment and monitoring are essential when using this intravenous solution. - Assess electrolyte status: verify serum sodium and glucose before infusion. - Monitor fluid balance: track input/output and signs of overload. - Adjust for renal impairment: reduce volume in patients with reduced clearance. - Use compatible IV sets: avoid mixing with incompatible drugs. - Observe for allergic reactions: discontinue if hypersensitivity occurs. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Certain concomitant therapies can modify the safety or efficacy of the solution.

Major Interactions (Avoid): - Hypertonic saline infusions: may cause excessive sodium load. - High‑dose glucose infusions: increase risk of severe hyperglycemia. - Loop diuretics: can exacerbate electrolyte shifts when combined with large volumes.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may potentiate hypotensive effects. - NSAIDs: can affect renal handling of sodium and fluid. - Insulin therapy: requires close glucose monitoring to avoid hypoglycemia after glucose infusion.